UK to set up chlamydia screening programme:
This article was originally published in Clinica
The UK government is considering implementing a national screening programme for chlamydia. It will carry out a feasibility study on the programme later this year in two pilot areas. The move comes as part of a drive to stem the increased incidence of the disease, which can cause pelvic inflammation disease which in turn can lead to sterility. A urine-based test to detect the disease will be offered to sexually active women under the age of 25 and older women who have more than one partner in a year. If a women is found to have the disease, her partner will also be offered the test.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.